Jump Financial, LLC Glaukos Corp Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$76.4 - $96.33 $3.31 Million - $4.17 Million	-43,339 Reduced 91.07%	4,250 $400,000
Q4 2023 Oct 21, 2024	BUY	$59.53 - $85.11 $2.37 Million - $3.39 Million	39,829 Added 513.26%	47,589 $3.78 Million
Q4 2023 Feb 07, 2024	BUY	$59.53 - $85.11 $2.37 Million - $3.39 Million	39,829 Added 513.26%	47,589 $3.78 Million
Q3 2023 Oct 21, 2024	BUY	$69.23 - $79.09 $195,297 - $223,112	2,821 Added 57.12%	7,760 $583,000
Q3 2023 Nov 07, 2023	BUY	$69.23 - $79.09 $195,297 - $223,112	2,821 Added 57.12%	7,760 $583,000
Q2 2023 Oct 21, 2024	BUY	$45.44 - $71.21 $224,428 - $351,706	4,939 New	4,939 $351,000
Q2 2023 Aug 07, 2023	BUY	$45.44 - $71.21 $224,428 - $351,706	4,939 New	4,939 $351,000
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $602,361 - $1.07 Million	-12,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $927,862 - $1.24 Million	12,700 New	12,700 $1.08 Million
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $791,703 - $1.1 Million	-11,241 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $549,684 - $845,997	11,241 New	11,241 $846,000

355

47.8M

124K

185K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.14B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.